This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-iccc3extendedcode defines the following codes:
Code | Display |
Ia.1 | Precursor cell leukaemias |
Ia.2 | Mature B-cell leukaemias |
Ia.3 | Mature T-cell and NK cell leukaemias |
Ia.4 | Lymphoid leukaemia, NOS |
IIb.1 | Precursor cell lymphomas |
IIb.2 | Mature B-cell lymphomas (except Burkitt lymphoma) |
IIb.3 | Mature T-cell and NK-cell lymphomas |
IIb.4 | Non-Hodgkin lymphomas, NOS |
IIIa.1 | Ependymomas |
IIIa.2 | Choroid plexus tumour |
IIIc.1 | Medulloblastomas |
IIIc.2 | PNET |
IIIc.3 | Medulloepithelioma |
IIIc.4 | Atypical teratoid/rhabdoid tumour |
IIId.1 | Oligodendrogliomas |
IIId.2 | Mixed and unspecified gliomas |
IIId.3 | Neuroepithelial glial tumours of uncertain origin |
IIIe.1 | Pituitary adenomas and carcinomas |
IIIe.2 | Tumours of the sellar region (craniopharyngiomas) |
IIIe.3 | Pineal parenchymal tumours |
IIIe.4 | Neuronal and mixed neuronal-glial tumours |
IIIe.5 | Meningiomas |
VIa.1 | Nephroblastoma |
VIa.2 | Rhabdoid renal tumour |
VIa.3 | Kidney sarcomas |
VIa.4 | pPNET of kidney |
VIIIc.1 | Ewing tumour and Askin tumour of bone |
VIIIc.2 | pPNET of bone |
VIIId.1 | Malignant fibrous neoplasms of bone |
VIIId.2 | Malignant chordomas |
VIIId.3 | Odontogenic malignant tumours |
VIIId.4 | Miscellaneous malignant bone tumours |
IXb.1 | Fibroblastic and myofibroblastic tumours |
IXb.2 | Nerve sheath tumours |
IXb.3 | Other fibromatous neoplasms |
IXd.1 | Ewing tumour and Askin tumour of soft tissue |
IXd.2 | pPNET of soft tissue |
IXd.3 | Extrarenal rhabdoid tumour |
IXd.4 | Liposarcomas |
IXd.5 | Fibrohistiocytic tumours |
IXd.6 | Leiomyosarcomas |
IXd.7 | Synovial sarcomas |
IXd.8 | Blood vessel tumours |
IXd.9 | Osseous and chondromatous neoplasms of soft tissue |
IXd.10 | Alveolar soft parts sarcoma |
IXd.11 | Miscellaneous soft tissue sarcomas |
Xa.1 | Intracranial and intraspinal germinomas |
Xa.2 | Intracranial and intraspinal teratomas |
Xa.3 | Intracranial and intraspinal embryonal carcinomas |
Xa.4 | Intracranial and intraspinal yolk sac tumour |
Xa.5 | Intracranial and intraspinal choriocarcinoma |
Xa.6 | Intracranial and intraspinal tumours of mixed forms |
Xb.1 | Malignant germinomas of extracranial and extragonadal sites |
Xb.2 | Malignant teratomas of extracranial and extragonadal sites |
Xb.3 | Embryonal carcinomas of extracranial and extragonadal sites |
Xb.4 | Yolk sac tumour of extracranial and extragonadal sites |
Xb.5 | Choriocarcinomas of extracranial and extragonadal sites |
Xb.6 | Other and unspecified malignant mixed germ cell tumors of extracranial and extragonadal sites |
Xc.1 | Malignant gonadal germinomas |
Xc.2 | Malignant gonadal teratomas |
Xc.3 | Gonadal embryonal carcinomas |
Xc.4 | Gonadal yolk sac tumour |
Xc.5 | Gonadal choriocarcinoma |
Xc.6 | Malignant gonadal tumours of mixed forms |
Xc.7 | Malignant gonadal gonadoblastoma |
XIf.1 | Carcinomas of salivary glands |
XIf.2 | Carcinomas of colon and rectum |
XIf.3 | Carcinomas of appendix |
XIf.4 | Carcinomas of lung |
XIf.5 | Carcinomas of thymus |
XIf.6 | Carcinomas of breast |
XIf.7 | Carcinomas of cervix uteri |
XIf.8 | Carcinomas of bladder |
XIf.9 | Carcinomas of eye |
XIf.10 | Carcinomas of other specified sites |
XIf.11 | Carcinomas of unspecified site |
XIIa.1 | Gastrointestinal stromal tumour |
XIIa.2 | Pancreatoblastoma |
XIIa.3 | Pulmonary blastoma and pleuropulmonary blastoma |
XIIa.4 | Other complex mixed and stromal neoplasms |
XIIa.5 | Mesothelioma |
XIIa.6 | Other specified malignant tumours |